Expand ARDX Menu
ARDX MENU

ARDX Latest Press Releases

-- March 12, 2026 --

Ardelyx Announces Recipients of the 2026 Derek Forfang Patient Advocate Award Globe Newswire 8:00 AM

-- March 9, 2026 --

Ardelyx Announces Publication of a Review Article Demonstrating Rapid and Meaningful Symptom Relief with Tenapanor in IBS-C Globe Newswire 4:05 PM

-- March 4, 2026 --

Ardelyx to Participate in Upcoming Investor Conferences Globe Newswire 8:00 AM

-- February 24, 2026 --

Ardelyx and the LPGA Announce Multi-Year Partnership to Break Stigma Around Digestive Health Issues Impacting Millions Globe Newswire 8:00 AM

-- February 19, 2026 --

Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update Globe Newswire 4:01 PM

-- February 5, 2026 --

Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026 Globe Newswire 8:00 AM

-- February 3, 2026 --

Ardelyx Receives New Patent for Tenapanor Globe Newswire 8:29 AM

-- January 28, 2026 --

First Patient Dosed in ACCEL: Phase 3 Chronic Idiopathic Constipation Study of IBSRELA Globe Newswire 8:29 AM

-- January 23, 2026 --

Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets Globe Newswire 12:56 PM

-- January 8, 2026 --

Ardelyx Reports Preliminary 2025 Revenue and Provides 2026 Strategic Outlook Globe Newswire 8:30 AM

-- November 7, 2025 --

Real-World Evidence Studies of XPHOZAH (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week Globe Newswire 4:05 PM

-- November 5, 2025 --

Ardelyx to Participate at the Jefferies Global Healthcare Conference in London Globe Newswire 8:00 AM

-- November 4, 2025 --

Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference Globe Newswire 8:00 AM

-- October 30, 2025 --

Ardelyx Reports Third Quarter 2025 Financial Results and Provides Corporate Update Globe Newswire 4:01 PM

-- October 28, 2025 --

Ardelyx Presents Data that Continues to Support the Benefits of IBSRELA (tenapanor) at the American College of Gastroenterology's 2025 Annual Meeting Globe Newswire 8:01 AM
Market Data Delayed 15 Minutes